Kourtis K, Jennifer S, Read J, Jamieson D. Pregnancy and infection. N Engl J Med 2014; 370: 2211-8.
Aagaard-Tillery K, Silver R, and Dalton J. Immunology of normal pregnancy. Semin Fetal Neonatal Med 2006; 11: 279-95.
Mikyas Y, Aziz N, Harawa N, et al. Immunologic activation during pregnancy: serial measurement of lymphocyte phenotype and serum activation molecules in HIV-infected and uninfected women. J Reprod Immunol 1997; 33: 157-70.
Burns D, Nourjah P, Wright D, et al. Changes in immune activation markers during pregnancy and postpartum. J Reprod Immunol 1999; 42: 147-65.
Truong H, Sim M, Dillon M, et al. Correlation of immune activation during late pregnancy and early postpartum with increases in plasma hiv rna, cd4/cd8 t cells, and serum activation markers. Clin Vaccine Immunol 2010; 17(12): 2024-8.
Silver R. Immune activation early in pregnancy: trouble down the road. Am J Obstet Gynecol 2008; 199(4): 327-8.
Hunt PW. Role of immune activation in hiv pathogenesis. Curr HIV/AIDS Rep 2007; 4: 42-7.
Hunt PW, Brenchley J, Sinclair E, et al. Relationship between t cell activation and cd4(+) t cell count in hiv-seropositive individuals with undetectable plasma hiv rna levels in the absence of therapy. J Infect Dis 2008; 197: 126-33.
Veazey RS, Lackner AA. HIV swiftly guts the immune system. Nat Med 2005; 11: 469-70.
Brenchley J, Price D, Schacker T, et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med 2006; 12: 1365-71.
Marchetti G, Bellstri GM, Borghi E, et al. microbial translocation is associated with sustained failure in cd4+ t-cell reconstitution in hiv-infected patients on long-term highly active antiretroviral therapy. AIDS 2008; 22: 2035-44.
Marchetti G, Tincati C, Silvestri G. microbial translocation in the pathogenesis of HIV infection and AIDS. Clin Microbiol Rev 2013; 26: 2-18.
Burgener A, McGowan I, and Klatt N. HIV and mucosal barrier interactions: consequences for transmission and pathogenesis. Curr Opin Immunol 2015; 36: 22-30.
Zevin A, McKinnon L, Burgener A, Klatt N. Microbial translocation and microbiome dysbiosis in HIV-associated immune activation. Curr Opin HIV AIDS 2016; 11: 182-90.
Sandler NG, Koh C, Roque A, et al. Host response to translocated microbial products predicts outcomes of patients with HBV or HCV infection. Gastroenterology 2011; 141: 1220-30.
Caradonna L, Mastronardi M, Magrone T, et al. Biological and clinical significance of endotoxemia in the course of hepatitis C virus infection. Curr Pharm Des 2002; 8: 995-1005.
Page E, Nelson M, Kelleher P. HIV and hepatitis C coinfection: Pathogenesis and microbial translocation. Curr Opin HIV AIDS 2011; 6: 472-7.
Jiang W, Lederman MM, Hunt P, et al. Plasma levels of bacterial DNA correlate with immune activation and the magnitude of immune restoration in persons with antiretroviral-treated HIV infection. J Infect Dis 2009; 199: 1177-85.
Mor Gil, Aldo Paulomi, Alvero Ayesha. The unique immunological and microbial aspects of pregnancy. Nat Rev Immunol 2017; 17: 469-82.
Loewendorf A, Nguyen T, Yesayan M, Kahn D. Normal human pregnancy results in maternal immune activation in the periphery and at the uteroplacental interface. PLoS One 2014; 9: 1-13.
Hunt P, Martin J, Sinclair E, et al. Valganciclovir reduces t cell activation in HIV-infected individuals with incomplete cd41 T cell recovery on antiretroviral therapy. J Infect Dis 2011; 203: 1474-83.